Sigyn Therapeutics SIGY
OTC SIGY
$0.04 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sigyn Therapeutics, Inc. (SIGY) Net Cash Flow (2016 - 2025)

Updated

Sigyn Therapeutics' Net Cash Flow was $85,112 in Q3 2025, down 23.4% from $111,144 a year earlier.

Analysis

Sigyn Therapeutics, Inc. (SIGY) Net Cash Flow (2016 - 2025) Analysis & Trends

On a trailing twelve-month basis, Sigyn Therapeutics' Net Cash Flow was -$79,217 through Sep 30, 2025; for FY2024, it came in at $454.00, down 86.4% from FY2023.

  • In earlier years, Net Cash Flow was $3,334 in FY2023, -$332,600 in FY2022, $256,554 in FY2021 (+204.0%) and $84,402 in FY2020.
  • Quarterly Net Cash Flow has moved between -$557,021 (Q3 2021) and $1.05 million (Q2 2021) over five years.
  • Compared with a year earlier, Net Cash Flow was higher in 1 of the last four quarters, with an average decline of 10.4%.
  • Per Business Quant data, SIGY's Net Cash Flow in the three quarters before Q3 2025 was -$12,436 (Q2 2025), $751.00 (Q1 2025) and -$152,644 (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 85,112.00
Jun 30, 2025 -12,436.00
Mar 31, 2025 751.00
Dec 31, 2024 -152,644.00
Sep 30, 2024 111,144.00
Jun 30, 2024 20,806.00
Mar 31, 2024 21,148.00
Dec 31, 2023 -52,894.00
Sep 30, 2023 40,951.00
Jun 30, 2023 -298,694.00
Mar 31, 2023 313,971.00
Dec 31, 2022 -19,767.00
Sep 30, 2022 20,832.00
Jun 30, 2022 -73,235.00
Mar 31, 2022 -259,571.00
Dec 31, 2021 -162,020.00
Sep 30, 2021 -557,021.00
Jun 30, 2021 1.05 Mn
Mar 31, 2021 -77,295.00
Dec 31, 2020 -280,743.00
API Access

Sigyn Therapeutics, Inc. Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=SIGY&period=max&api_key=YOUR_API_KEY